US EditionA Possible New Era in Pain Management: FDA Approves a Novel Non-Opioid Analgesic
3 Articles
3 Articles
We don't know how to measure pain in newborns and it's an old problem: until the age of 80 they were operated without anesthesia.
A systematic review concludes that none of the scales available to evaluate pain in newborns is reliable for clinical practice, a problem that comes from afar and gets worse with premature ones, which are still intubated without analgesia in many Hemeroteca centers - Why don't we remember childhood?A study shows that babies do process memories and open the door to recovering them Knowing if a newborn feels pain is a challenge to medicine and can…
A Possible New Era in Pain Management: FDA Approves a Novel Non-Opioid Analgesic
The availability of suzetrigine may represent a critical step in addressing the nation’s pain management crisis. While questions remain about its cost, adoption, and long-term efficacy, its novel mechanism and positive clinical results offer a promising alternative to opioids.
ANALGESIC EFFICACY OF TRAMADOL/DEXKETOPROFEN VS IBUPROFEN AFTER IMPACTED LOWER THIRD MOLAR EXTRACTION: A RANDOMIZED CONTROLLED CLINICAL TRIAL
Impacted third molar extraction is associated with acute moderate-to-severe pain for up to 48 hours post-surgery. This trial was designed to compare t…
Coverage Details
Bias Distribution
- 50% of the sources lean Left, 50% of the sources lean Right
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage